X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Search Again

We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms

Showing 20 out of 28,805 Resources on page 1036

NEI (neuro-endocrine-immune) Network Database

Version 1.0 database for neuro-endocrine-immune (dbNEI) is a web-based knowledge resource specific for the NEI systems. It provides a knowledge environment for understanding the main regulatory systems of NEI in a molecular level. dbNEI provides a knowledge environment for understanding the main regulatory systems of NEI in a molecular level. dbNEI collects 1,058 NEI related signal molecules, their 940 interactions and 72 affiliated tissues from the Cell Signaling Networks database and manually selects 982 NEI papers from PubMed. NEI related information, such as signal transductions, regulations and control subunits, are integrated. Especially, dbNEI represents as graphic visualization, by which control subunits can be automatically obtained according to the inquiring issues. Version 2.0: We updated the database in four aspects. 1. Recruiting new NEI genes and compounds. 2. Adding KEGG,HPRD,Transcription factor and microRNA target relations. 3. Collecting drug-gene and disease-gene relation. 4. Building multi-layer network for drug-NEI-disease.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

NIMH/SNIDD Tracer Database Initiative

A database of imaging probes useful for preclinical and clinical studies. The National Institute of Mental Health (NIMH) and the Society for Non-Invasive Imaging in Drug Development (SNIDD) are in the process of creating a centralized, searchable PET, SPECT, and MRI tracer database as a resource for the scientific community. The goal of this effort is to promote the use of imaging probes in preclinical and clinical research and in drug discovery to accelerate the identification and validation of novel targets for therapeutic intervention in human diseases, especially those with central nervous system components. NIMH will maintain the tracer database as part of the Psychoactive Drug Screening Program (PDSP). The database will contain records for each radiotracer with relevant information such as target, research uses, pharmacology, pharmacokinetics, synthesis protocols, toxicology and safety data, dosimetry, other clinical data, IND info, permission to cross-reference pharmacology, toxicology, or safety data in a drug master file (if an IND exists), contact information, patent, etc. with appropriate safeguards in place to protect the intellectual property of proprietary compounds.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

ActiveDriver

A statistical method for interpreting variations in protein sequence (e.g. coding SNPs in the population, SNVs in cancer genomes) in the context of protein post-translational signaling modifications.

  • Resource
  • SciCrunch
  • 13 years ago - by Anonymous

IUBMB-Nicholson Minimaps

Minimaps are designed to supplement the Metabolic Pathways Charts by enlarging selected major individual pathways so as to illustrate additional aspects of metabolism such as Membranes, Compartmentation, Organs, Organelles, Shuttles and Regulation. The selection is designed to stimulate the exploration of the pathways and make metabolism more meaningful.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

American Parkinson's Disease Association National Young Onset Center

An organization that is centered around the education of younger Parkinson's disease patients as well as their families, friends and healthcare professionals. They primarily provide educational and support programs and services that are designed to help younger Parkinson's patients manage the disease and maintain a healthy lifestyle. The center provides information about treatment options, clinical trials, support groups, person to person chats, local chapters,regional referral information, and Parkinson's related events.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

MAP MANAGER QT

A graphic, interactive program to map quantitative trait loci by regression methods; MAP MANAGER CLASSIC enhanced by quantitative trait mapping. (entry from Genetic Analysis Software)

  • Resource
  • SciCrunch
  • 14 years ago - by Anonymous

Database of Domain Interactions and Bindings

DDIB collects information of domain-domain interactions and domain interactions with biological molecules such as RNA, DNA, peptides, inorganic ions, phospholipids and cholesterols. Most of the data were extracted automatically from publication abstracts in MEDLINE, and the rest were collected from other public databases, research laboratories and individual scientists. In addition, DDIB includes many putative domain-domain interactions inferred from documented protein-protein interactions. To provide comprehensive knowledge of a domain, DDIB also integrates relevant information from PFAM, InterPro, GO and KEGG databases.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

Parkinson's Disease Research, Education and Clinical Center

An organization involved in the clinical research of Parkinson's disease. They are involved in a variety of clinical research including: deep brain stimulation (DBS), drug therapies, gait and falling issues, depression and other psychiatric problems, non-motor fluctuations, basic science and olfactory function during Parkinson's disease.

  • Resource
  • SciCrunch
  • 16 years ago - by Anonymous

Michael Stern Parkinsons Research Foundation

THIS RESOURCE IS NO LONGER IN SERVICE, documented on May 18th, 2016. A foundation that was founded in 2001, and sponsors academic centers throughout the US. The MIchael Stern Parkinson's Research Foundation focuses its efforts mainly on finding the causes of the disease, finding effective treatments, and discovering a cure for the disease. The foundation is notably looking into dopamine and its effects on neural connections, as well its possibility to be used for treatment.<br/>Dr. Greengard has assembled a close knit group of more than 25 outstanding scientists who are focused on translating the fundamental understandings about the dopamine system into new treatments for Parkinson's. The core team of researchers is based at the Stern Foundation laboratory on the campus of The Rockefeller University interacts continually with collaborators from the United Kingdom, France, Sweden, Italy, Japan and Korea. This global presence ensures that no promising research lead is overlooked, and that progress can be made on multiple fronts simultaneously. As the Foundation grew it was able to expand its support for critical neurological research to two other institutions, Harvard University's McLean Hospital, where we support the research of Dr. Ole Isacson whose research lab, The Stern Center for Neuroregeneration Research is using gene therapy to protect the most vulnerable neurons in PD models; and the Institute for Neurodegenerative Disorders, where Yale Professors Dr. Ken Marek and Dr. John Seibyl are developing novel tools for early detection and monitoring of Parkinson's disease by studying physiologic, biochemical and neuroimaging biomarkers for non-dominergic manifestations of Parkinsonism. :NIF thanks the Parkinson's Disease Foundation, http://www.pdf.org for their referral of this resource to us.

  • Resource
  • SciCrunch
  • 15 years ago - by Anonymous

Laboratory of Molecular Neuroscience, University of Oslo

A laboratory that investigates the molecular mechanisms involved in the development of acute and chronic neurodegenerative disease, with a focus on the role of glutamate excitotoxicity. It aims at unraveling the molecular basis for cell death and edema development in stroke, and explores the pathophysiology of Alzheimer's disease and temporal lobe epilepsy. The main objective of the LMN is to advance understanding of the role of glutamate, as a transmitter substance in the normal brain and as a mediator of excitotoxicity in pathological conditions such as stroke. To this end the LMN employs several vital and nonvital imaging techniques. Model systems includes organotypic slice cultures and transgenic animals. An important focus of the LMN is to explore the role of DNA damage and repair in the pathogenesis of neurodegenerative disease. LMN is also engaged in research on molecular mechanism underlying brain edema, epilepsy, and Alzheimer's disease.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

Parkinsons Center at Dartmouth-Hitchcock Medical Center

A Parkinson's disease portal that provides information, materials, and programs to help Parkinson's patients and their care partners manage their everyday lives. The Center aims to enhance the quality of life for people with Parkinson's and their care partners and increase public awareness and education on Parkinson's disease. It provides resources for regional support group meetings, referrals to regional physicians, allied health professionals, home care agencies, and other resources, and information on current therapies and research programa. It also provides materials such as informational pamphlets and booklets, videos, DVDs, newsletters, and educational materials.

  • Resource
  • SciCrunch
  • 16 years ago - by Anonymous

Cure Parkinson's Trust

A patient led charity that funds research which will have an impact on the lives of people with Parkinson's, with the hope of an eventual cure for the condition. The Cure Parkinson's Trust has the clear goal of finding a cure for Parkinson's disease by investing in under resourced and underfunded projects that offer a possible cure in the future. This trust's primary role is identifying, funding and evaluating research projects, as well as hosting scientific forums to bring together relevant scientists within the field to discuss key areas of research and technology. Cure Parkinson's provides researchers with information on current research, research events, and the ability to apply for grants through the Cure Parkinson's Trust.

  • Resource
  • SciCrunch
  • 16 years ago - by Anonymous

Effects of CoEnzyme Q10 in Early Parkinson's Disease

THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 17, 2013. This site has a dataset from the QE2 Study: Effects of CoEnzyme Q10 in Early Parkinson's Disease, was an NINDS funded pilot study of 80 subjects with early untreated Parkinson's disease (PD). The PI was Clifford Shults, MD at UCSD. It was a randomized, double-blind, parallel group comparison of three doses of coenzyme Q10 (CoQ10) (300, 600 and 1200 mg/day) versus placebo in patients and do not yet require treatment with levodopa. The QE2 Study: Effects of CoEnzyme Q10 in Early Parkinson's Disease, was an NINDS funded pilot study of 80 subjects with early untreated Parkinson's disease (PD). The PI was Clifford Shults, MD at UCSD. It was a randomized, double-blind, parallel group comparison of three doses of coenzyme Q10 (300, 600 and 1200 mg/day) versus placebo in patients and do not yet require treatment with levodopa or any other antiparkinsonian medication. Enrollment period May 1999 Feb. 2000; study participation ended June 2001.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

University of Southern California; Los Angeles; USA

American private research university in Los Angeles, California. Founded in 1880, it is the oldest private research university in California. USC has historically educated a large number of the nation's business leaders and professionals.

  • Organization
  • SciCrunch
  • 12 years ago - submitted by Timothy Tsui

Antibodies Online GmbH

Resells antibodies incorporating quality control metrics for antibody reagents. Antibodies-online is based in Germany and provides valuable content in terms of information about antibodies, recent research news and specific news about current antibodies. All these informations are generated by antibodies-online staff or external databases like Pubmed, EMBL Harvester or from Google Scholar.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

Mouse Gene Expression at the BC Cancer Agency

A portal to the Mouse Atlas of Gene Expression Project and Dissecting Gene Expression Networks in Mammalian Organogenesis Project. This Atlas will define the normal state for many tissues by determining, in a comprehensive and quantitative fashion, the number and identity of genes expressed throughout development. The resource will be comprehensive, quantitative, and publicly accessible, containing data on essentially all genes expressed throughout select stages of mouse development. Serial Analysis of Gene Expression (SAGE) is the gene expression methodology of choice for this work. Unlike expressed sequence tags (ESTs) and gene chip data, SAGE data are independent of prior gene discovery and are quantitative. Furthermore, SAGE data are digital, easily exchanged between laboratories for comparison and can be added to by scientists for years to come. Thus, this Atlas will include a data structure and data curation strategy that will facilitate the ongoing collection of gene expression data, even after the completion of this project. The Mouse Atlas project compromises 202 SAGE Libraries from 198 tissues. The list of libraries is available in a number of different groupings, including groups of libraries taken from specific tissue locations and libraries taken from specific developmental stages. Furthermore, this atlas will assemble gene expression profiles for a few focused experiments that will test hypotheses related to the techniques employed, tumor models and models of abnormal development. This will test the resource and provide quality control, validation and demonstrate applicability. Additionally, The Mammalian Organogenesis - Regulation by Gene Expression Networks (MORGEN) project will provide a complete, permanent, and accurate picture of mouse gene expression in the heart (atrioventricular canal and outflow tract), pancreas, and liver; new techniques to understand the interplay of proteins governing the expression of genes key to the development of these organ systems; and the identification of the master regulatory switches that control development of the tissues.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

3D MRI Atlas of Mouse Development

THIS RESOURCE IS NO LONGER IN SERVICE, documented May 10, 2017. A pilot effort that has developed a centralized, web-based biospecimen locator that presents biospecimens collected and stored at participating Arizona hospitals and biospecimen banks, which are available for acquisition and use by researchers. Researchers may use this site to browse, search and request biospecimens to use in qualified studies. The development of the ABL was guided by the Arizona Biospecimen Consortium (ABC), a consortium of hospitals and medical centers in the Phoenix area, and is now being piloted by this Consortium under the direction of ABRC. You may browse by type (cells, fluid, molecular, tissue) or disease. Common data elements decided by the ABC Standards Committee, based on data elements on the National Cancer Institute''s (NCI''s) Common Biorepository Model (CBM), are displayed. These describe the minimum set of data elements that the NCI determined were most important for a researcher to see about a biospecimen. The ABL currently does not display information on whether or not clinical data is available to accompany the biospecimens. However, a requester has the ability to solicit clinical data in the request. Once a request is approved, the biospecimen provider will contact the requester to discuss the request (and the requester''s questions) before finalizing the invoice and shipment. The ABL is available to the public to browse. In order to request biospecimens from the ABL, the researcher will be required to submit the requested required information. Upon submission of the information, shipment of the requested biospecimen(s) will be dependent on the scientific and institutional review approval. Account required. Registration is open to everyone.. Documented on October, 01, 2019.<br/>3D digital atlas of normal mouse development constructed from magnetic resonance image data. The download is a zipped file containing the six atlases Theiler Stages (ts) 13, 21,23, 24, 25 and 26 and MRI data for an unlabeled ts19 embryo. To view the atlases, download and install MBAT from: http://mbat.loni.ucla.edu Specimens were prepared in aqueous, isotonic solutions to avoid tissue shrinkage. Limited specimen handling minimized physical perturbation of the embryos to ensure accurate geometric representations of developing mouse anatomy. Currently, the atlas contains orthogonal sections through MRI volumes, three stages of embryos that have annotated anatomy, photographs of several stages of development, lineage trees for annotated embryos and a gallery of images and movies derived from the annotations. Anatomical annotations can be viewed by selecting a transverse section and selecting a pixel on the displayed slice.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

Gene Atlas

This website allows visitors to search for genes of interest based on their spatial expression patterns in the Postnatal Day 7 mouse brain. Geneatlas provides two searching tools: A graphical interface for customized spatial queries; A textual interface for querying annotated structures. Geneatlas is the product of a collaboration between researchers at Baylor College of Medicine, Rice University, and University of Houston.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

Connectionist Models of Cognitive, Affective, Brain, and Behavioral Disorders

THIS RESOURCE IS NO LONGER IN SERVICE, documented August 23, 2016. This site aims to provide a discussion and source list for connectionist and neural network models of disorders associated with mental or brain conditions. Recent connectionist and neural network models of behavior, information processing patterns, and brain activity present in people with cognitive, affective, brain, and behavioral disorders are reviewed on this web site. Ways that assumptions regarding normal and disordered behavior may be represented in connectionist models are discussed for features of various disorders. Similarities and differences between the models and criteria for their evaluation are presented, and suggestions for inclusion of information which may help to make these models more directly comparable in the future are considered. References to Connectionist Models of Cognitive, Affective, Brain, and Behavioral Disorders include: General Neural Network Information Reviews, General Introductions, and Calls for More Connectionist Models of Mental Disorders Models of Psychopathologies and Psychiatric Disorders Models of Cognitive, Affective, Brain, and Behavioral Disorders Not Associated with Psychopathology Additionally, Web Sites for Neural Network Modelers of Disorder are provided.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous

HHsim: Graphical Hodgkin-Huxley Simulator

A graphical simulation of a section of excitable neuronal membrane using the Hodgkin-Huxley equations. It provides full access to the Hodgkin-Huxley parameters, membrane parameters, stimulus parameters, and ion concentrations. In contrast with NEURON or GENESIS, which are vastly more sophisticated research tools, HHsim is simple educational software designed specifically for graduate or undergraduate neurophysiology courses. The user interface can be mastered in a couple of minutes and provides many ways for the student to experiment. Also included are sample exercises that use the simulator. HHsim is available as a Windows, Mac, or Unix executable file that does not require a Matlab license. Source code is included. It is also available in source-only form if you have Matlab R2007a or later. The latest release of HHsim is version 3.1, released February 16, 2008.

  • Resource
  • SciCrunch
  • 17 years ago - by Anonymous